Assessment of demand for male contraceptives: A multi-country study

IF 3.2 2区医学 Q1 ANDROLOGY

Andrology Pub Date : 2024-08-19 DOI:10.1111/andr.13726

Japneet Kaur, Dhananjay Vaidyanathan Rohini, LinChiat Chang, Allie Gugliotti, Steve Kretschmer

{"title":"Assessment of demand for male contraceptives: A multi-country study","authors":"Japneet Kaur, Dhananjay Vaidyanathan Rohini, LinChiat Chang, Allie Gugliotti, Steve Kretschmer","doi":"10.1111/andr.13726","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>As of 2019, high unmet contraceptive needs in low- and middle-income countries result in nearly half of all pregnancies being unintended. Additional male contraceptive options could help, but gaps remain in assessing demand for them. As the development of novel male contraceptives progresses, addressing these gaps would help inform policy and scientific direction.</p>\n </section>\n \n <section>\n \n <h3> Objectives</h3>\n \n <p>Measure consumer demand for novel male contraceptives and identify product attributes associated with men's preferences.</p>\n </section>\n \n <section>\n \n <h3> Materials & methods</h3>\n \n <p>A cross-sectional, probability-based-sample survey was conducted with 12,435 sexually active, fertile cisgender, heterosexual men aged 18–60 years, and 9,122 of their female partners in Bangladesh, Vietnam, Kenya, Nigeria, DR Congo, and Côte d'Ivoire from May 2021 to October 2022. The survey was also conducted in the United States among 3,243 of these men in April 2022. A follow-up with 3,070 men in May 2023 assessed potential changes in demand after the Supreme Court's Dobbs v. Jackson Women's Health Organization decision. The surveys assessed contraceptive use, perceptions, and sociodemographic characteristics, and a discrete choice experiment evaluated preferences for 11 potential product attributes. Data from female partners in the six LMICs indicated their interest and trust in male partners’ contraceptive use.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>On average, 61% of men showed interest in trying novel male contraceptives in their first year of availability, ranging from 39% and 49% (pre- and post-Dobbs) in the United States to 76% in Nigeria and Bangladesh. Form of administration and time of use drove men's product preferences. Female partners’ interest and trust in male contraceptive use were high across geographies.</p>\n </section>\n \n <section>\n \n <h3> Discussion</h3>\n \n <p>This study reveals strong latent demand for novel male contraceptives, highlighting the potential for novel male methods to meet unmet needs, and female partners’ trust in men to use them.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>High demand for novel male contraceptives among men and their partners exists, supporting investment in their development.</p>\n </section>\n </div>","PeriodicalId":7898,"journal":{"name":"Andrology","volume":"12 7","pages":"1512-1524"},"PeriodicalIF":3.2000,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/andr.13726","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Andrology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/andr.13726","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANDROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

As of 2019, high unmet contraceptive needs in low- and middle-income countries result in nearly half of all pregnancies being unintended. Additional male contraceptive options could help, but gaps remain in assessing demand for them. As the development of novel male contraceptives progresses, addressing these gaps would help inform policy and scientific direction.

Objectives

Measure consumer demand for novel male contraceptives and identify product attributes associated with men's preferences.

Materials & methods

A cross-sectional, probability-based-sample survey was conducted with 12,435 sexually active, fertile cisgender, heterosexual men aged 18–60 years, and 9,122 of their female partners in Bangladesh, Vietnam, Kenya, Nigeria, DR Congo, and Côte d'Ivoire from May 2021 to October 2022. The survey was also conducted in the United States among 3,243 of these men in April 2022. A follow-up with 3,070 men in May 2023 assessed potential changes in demand after the Supreme Court's Dobbs v. Jackson Women's Health Organization decision. The surveys assessed contraceptive use, perceptions, and sociodemographic characteristics, and a discrete choice experiment evaluated preferences for 11 potential product attributes. Data from female partners in the six LMICs indicated their interest and trust in male partners’ contraceptive use.

Results

On average, 61% of men showed interest in trying novel male contraceptives in their first year of availability, ranging from 39% and 49% (pre- and post-Dobbs) in the United States to 76% in Nigeria and Bangladesh. Form of administration and time of use drove men's product preferences. Female partners’ interest and trust in male contraceptive use were high across geographies.

Discussion

This study reveals strong latent demand for novel male contraceptives, highlighting the potential for novel male methods to meet unmet needs, and female partners’ trust in men to use them.

Conclusion

High demand for novel male contraceptives among men and their partners exists, supporting investment in their development.

Abstract Image

查看原文本刊更多论文

男性避孕药具需求评估：一项多国研究。

背景：截至 2019 年，中低收入国家未得到满足的避孕需求居高不下，导致近一半的意外怀孕。增加男性避孕药具的选择可能会有所帮助，但在评估需求方面仍存在差距。随着新型男性避孕药研发的进展，弥补这些差距将有助于为政策和科学发展指明方向：测量消费者对新型男性避孕药具的需求，并确定与男性偏好相关的产品属性：2021 年 5 月至 2022 年 10 月，在孟加拉国、越南、肯尼亚、尼日利亚、刚果民主共和国和科特迪瓦对 12,435 名 18-60 岁、性活跃、有生育能力的同性异性男性及其 9,122 名女性伴侣进行了基于概率的横断面抽样调查。2022 年 4 月，还在美国对其中的 3,243 名男性进行了调查。2023 年 5 月，对 3070 名男性进行了跟踪调查，以评估最高法院对多布斯诉杰克逊妇女健康组织案做出判决后需求的潜在变化。调查评估了避孕药具的使用情况、认知和社会人口特征，离散选择实验评估了对 11 种潜在产品属性的偏好。来自六个低收入和中等收入国家的女性伴侣的数据显示了她们对男性伴侣使用避孕药具的兴趣和信任：平均而言，61% 的男性在新型男性避孕药具上市的第一年表示有兴趣尝试，从美国的 39% 和 49%（多布斯之前和之后）到尼日利亚和孟加拉国的 76%不等。给药形式和使用时间决定了男性对产品的偏好。女性伴侣对男性使用避孕药具的兴趣和信任度在各个地区都很高：讨论：这项研究揭示了对新型男性避孕药具的潜在需求，强调了新型男性避孕方法在满足未满足需求方面的潜力，以及女性伴侣对男性使用新型男性避孕方法的信任：结论：男性及其伴侣对新型男性避孕药具的需求量很大，这支持对其开发进行投资。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Andrology ANDROLOGY-

CiteScore

9.10

自引率

6.70%

发文量

200

期刊介绍： Andrology is the study of the male reproductive system and other male gender related health issues. Andrology deals with basic and clinical aspects of the male reproductive system (gonads, endocrine and accessory organs) in all species, including the diagnosis and treatment of medical problems associated with sexual development, infertility, sexual dysfunction, sex hormone action and other urological problems. In medicine, Andrology as a specialty is a recent development, as it had previously been considered a subspecialty of urology or endocrinology